Burning Rock Biotech (BNR) Inventory Average (2020 - 2026)

Burning Rock Biotech (BNR) has reported Inventory Average for 7 consecutive years, with $8.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Inventory Average fell 3.62% year-over-year to $8.0 million; the TTM figure through Mar 2026 stood at $8.0 million (down 3.62% YoY), while the FY2025 annual figure was $7.8 million, down 15.16% from the prior year.
• Inventory Average came in at $8.0 million for Q1 2026 at Burning Rock Biotech, up from $7.8 million in the prior quarter.
• The five-year high for Inventory Average was $20.3 million in Q3 2022, with the low at $7.8 million in Q4 2025.
• Average Inventory Average over 5 years is $12.5 million, with a median of $9.3 million recorded in 2024.
• Across the five-year window, Inventory Average surged 58.06% in 2022 and sank 47.5% in 2024, its largest moves.
• Year by year, Inventory Average stood at $19.7 million in 2022, then tumbled by 45.67% to $10.7 million in 2023, then decreased by 20.95% to $8.5 million in 2024, then declined by 7.48% to $7.8 million in 2025, then rose by 1.4% to $8.0 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $8.0 million, $7.8 million, and $7.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.